Verrica Pharmaceuticals Inc. - COM (VRCA)

Historical Portfolio Holders from Q2 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
14.8M
Holdings value Q3 2024
$21.5M
Value change Q3 2024
-$32.4M
Grand Portfolio weight change Q3 2024
0%
Number of holders
77
Number of buys Q3 2024
39
Number of sells Q3 2024
-29
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 14.8M $21.5M -$32.4M $1.45 78
2024 Q2 18.6M $136M +$6.59M $7.29 73
2024 Q1 17.7M $105M -$1.73M $5.92 61
2023 Q4 18M $132M +$23.7M $7.32 64
2023 Q3 15.1M $58.5M +$1.49M $3.89 66
2023 Q2 14.6M $84.2M +$9.03M $5.77 64
2023 Q1 12.9M $84.2M +$15.1M $6.50 61
2022 Q4 10.8M $29.8M -$1.57M $2.75 49
2022 Q3 10.2M $29.9M -$2.47M $2.92 46
2022 Q2 11.3M $21.7M +$3.2M $1.92 51
2022 Q1 8.88M $72.1M -$553K $8.11 47
2021 Q4 8.95M $82M -$7.32M $9.16 43
2021 Q3 9.17M $115M -$9.41M $12.50 50
2021 Q2 9.94M $112M -$1.69M $11.30 53
2021 Q1 9.93M $150M +$14.7M $15.15 51
2020 Q4 8.96M $103M -$682K $11.51 44
2020 Q3 8.93M $69.1M +$677K $7.74 46
2020 Q2 8.8M $96.9M -$278K $11.01 44
2020 Q1 8.83M $96.5M -$4.77M $10.93 45
2019 Q4 9.2M $144M -$4.09M $15.89 52
2019 Q3 9.27M $137M +$4.18M $14.76 42
2019 Q2 9.02M $105M +$2.58M $11.62 40
2019 Q1 8.82M $97M +$5.66M $10.81 40
2018 Q4 8.45M $68.8M -$1.84M $8.15 41
2018 Q3 8.24M $134M -$2.33M $16.25 45
2018 Q2 8.31M $164M +$164M $19.73 28